Jankalyan Chain Of Blood Banks And Medical Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 16 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
About Jankalyan Chain Of Blood Banks And Medical Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madhav Mate, Shantanoo Joshi, Purnendu Saxena, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U85196PN2008NPL133215
- Company No.
133215
- Company Classification
Private Not For Profit Company
- Incorporation Date
15 Dec 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jankalyan Chain Of Blood Banks And Medical Services?
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dileep Wani  | Director | 15-Dec-2008 | Current |
| Atul Kulkarni | Director | 20-Jul-2013 | Current |
| Madhav Mate | Director | 15-Dec-2008 | Current |
| Shantanoo Joshi | Director | 15-Dec-2008 | Current |
| Purnendu Saxena | Director | 02-Mar-2023 | Current |
| Manjusha Kulkarni | Director | 15-Dec-2008 | Current |
Financial Performance of Jankalyan Chain Of Blood Banks And Medical Services.
Jankalyan Chain Of Blood Banks And Medical Services, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jankalyan Chain Of Blood Banks And Medical Services?
In 2017, Jankalyan Chain Of Blood Banks And Medical Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
V.Y. Institute Of Medical Science Private LimitedActive 15 years 10 monthsPurnendu Saxena is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jankalyan Chain Of Blood Banks And Medical Services?
Unlock and access historical data on people associated with Jankalyan Chain Of Blood Banks And Medical Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jankalyan Chain Of Blood Banks And Medical Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jankalyan Chain Of Blood Banks And Medical Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
